EUVIMEDEUVIMED entdecken
Crossref

The expression of keratin 17 and p27 predicts clinical outcomes in colorectal cancer

Mineui Hong, Jeong Won Kim, Soon Auck Hong, Joo Young Kim iD

APMIS · 2025

DOI: 10.1111/apm.13495 ↗

Kurz gefasst

Fachartikel in der Zeitschrift APMIS, 2025. Verfasst von Mineui Hong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Chung-Ang University Hospital, College of Medicine, Chung-Ang University, Seoul, South Korea. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Keratin-17, Cyclin-Dependent Kinase Inhibitor p27, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: This research was supported by the Chung-Ang University Research Grants in 2023., Chung-Ang University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Keratin 17 (K17) is frequently overexpressed, associated with poor prognosis in various cancers, and contributes to p27 degradation during cancer progression. Using immunohistochemistry, we evaluated K17 and p27 expression and assessed their biological behavior and prognostic significance in 326 colorectal cancers. High K17 expression was associated with poorly differentiated tumors, high pT classification, and lymph node metastases. Low p27 expression was associated with large tumors, high pT classification, lymphovascular invasion, and lymph node metastases. The overall survival of patients with high K17 expression was significantly worse than that of patients with low K17 expression [hazard ratio (HR) = 1.805, 95% confidence interval (CI) 1.169–2.787; p = 0.007]. Patients with low p27 expression showed significantly worse overall survival than those with high p27 expression (HR = 3.082, 95% CI 1.722–5.517; p < 0.001). When combining the results of K17 and p27 expression, the K17 high p27 low expression group showed the worst overall survival. On the contrary, the K17 high/low p27 high group showed the best overall survival (p < 0.001). Therefore, K17 high p27 low expression is an independent poor prognostic factor in colorectal cancer. Thus, high K17 and low p27 expression correlate with aggressive clinicopathologic behavior and can be used as poor prognostic markers in colorectal cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsKeratin-17Cyclin-Dependent Kinase Inhibitor p27Biomarkers, TumorHumansMaleFemaleMiddle AgedAgedPrognosisImmunohistochemistryAged, 80 and overAdultSurvival AnalysisLymphatic Metastasis

Stichwörter der Autor:innen

Colorectal cancerK17immunohistochemistryp27prognosis

Substanzen

Keratin-17Cyclin-Dependent Kinase Inhibitor p27Biomarkers, TumorKRT17 protein, human

Autor:innen und Institutionen

  • Department of Pathology, Chung-Ang University Hospital, College of Medicine, Chung-Ang University, Seoul, South Korea.
  • Department of Pathology, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, South Korea.

ORCID-Profile: Joo Young Kim

Förderung

  • This research was supported by the Chung-Ang University Research Grants in 2023.
  • Chung-Ang University

Zitieren

APA

Hong, M., Kim, J. W., Hong, S. A., & Kim, J. Y. (2025). The expression of keratin 17 and p27 predicts clinical outcomes in colorectal cancer. APMIS. https://doi.org/10.1111/apm.13495

Vancouver

Hong M, Kim JW, Hong SA, Kim JY. The expression of keratin 17 and p27 predicts clinical outcomes in colorectal cancer. APMIS. 2025. doi:10.1111/apm.13495

BibTeX
@article{Hong2025,
  author = {Hong, Mineui and Kim, Jeong Won and Hong, Soon Auck and Kim, Joo Young},
  title = {The expression of keratin 17 and p27 predicts clinical outcomes in colorectal cancer},
  journal = {APMIS},
  year = {2025},
  doi = {10.1111/apm.13495}
}
Kostenlos starten →